The financial opportunity within non-viral drug delivery systems market has been analyzed across the following segments:
- Type of Molecule
- Small Molecule
- Biologic
- Type of Biologic
- Antibodies
- DNA
- RNA
- Proteins / Peptides
- Type of Intracellular Drug Delivery Technologies
- Cell Penetrating Peptides
- Extracellular Vesicles
- Oligonucleotides
- Nanoparticles
- Polymers
- Target Therapeutic Area
- Infectious Diseases
- Oncological Disorders
- Genetic Disorders
- Neurological Disorders
- Hepatic Disorders
- Cardiovascular Disorders
- Other Disorders
- Type Of Payment Model
- Upfront Payments
- Milestone Payments
- Key Geographical Regions
- North America
- Europe
- Asia
- Latin America
- Middle East and North Africa (MENA)
- Rest of the world
The Non-Viral Drug Delivery Systems Market: Focus on Intracellular Technologies and Biologics (2nd Edition), 2022-2035, report features the following companies, which we identified to be key players in this domain:
- Alnylam Pharmaceuticals
- AstraZeneca
- Biond Biologics
- Code Biotherapeutics
- Eli Lilly
- Merck
- Novartis
- Roche
Table of Contents
- Preface
- Executive Summary
- Introduction
- Market Landscape
- Key Insights
- Company Competitiveness Analysis
- Company Profiles
- Patent Analysis
- Partnerships and Collaborations
- Opportunity Assessment Framework
- Market Forecast
- Conclusion
- Executive insights
- Appendix I: Tabulated data
- Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/non-viral-drug-delivery-systems-market.html
News article
AI-based Digital Pathology Market
Learn from experts: do you know about these emerging industry trends?
Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic?
Exploring How Artificial Intelligence Is Transforming Digital Pathology
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
